TW200603841A - Dispersible tablets comprising a benzoic acid derivative - Google Patents

Dispersible tablets comprising a benzoic acid derivative

Info

Publication number
TW200603841A
TW200603841A TW094111015A TW94111015A TW200603841A TW 200603841 A TW200603841 A TW 200603841A TW 094111015 A TW094111015 A TW 094111015A TW 94111015 A TW94111015 A TW 94111015A TW 200603841 A TW200603841 A TW 200603841A
Authority
TW
Taiwan
Prior art keywords
benzoic acid
dispersible tablets
acid derivative
weight
dispersible
Prior art date
Application number
TW094111015A
Other languages
English (en)
Inventor
Catherine Beauchamp
Jean-Pierre Cassiere
Florian Battung
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200603841A publication Critical patent/TW200603841A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW094111015A 2004-04-08 2005-04-07 Dispersible tablets comprising a benzoic acid derivative TW200603841A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408078.4A GB0408078D0 (en) 2004-04-08 2004-04-08 Organic compounds

Publications (1)

Publication Number Publication Date
TW200603841A true TW200603841A (en) 2006-02-01

Family

ID=32320645

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094111015A TW200603841A (en) 2004-04-08 2005-04-07 Dispersible tablets comprising a benzoic acid derivative

Country Status (14)

Country Link
US (1) US20080312302A1 (zh)
EP (1) EP1734924A1 (zh)
JP (1) JP2007532509A (zh)
CN (1) CN1997348A (zh)
AR (1) AR048864A1 (zh)
AU (2) AU2005230402A1 (zh)
BR (1) BRPI0509645A (zh)
CA (1) CA2559739A1 (zh)
GB (1) GB0408078D0 (zh)
PA (1) PA8629501A1 (zh)
PE (1) PE20060717A1 (zh)
RU (1) RU2396954C2 (zh)
TW (1) TW200603841A (zh)
WO (1) WO2005097062A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1945272B1 (en) 2005-11-01 2013-09-11 Novartis AG Method of scintigraphy
AU2007247112B2 (en) 2006-05-09 2010-08-26 Novartis Ag Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
MX2008014837A (es) * 2006-05-23 2008-12-01 Novartis Ag Metodo para el tratamiento de hemocromatosis hereditaria.
BRPI0720793A2 (pt) 2006-11-29 2014-03-11 Novartis Ag SAIS E FORMAS CRISTALINAS DE ÁCIDO 4-[3,5-BIS(2-HIDRÓXI FENIL)-[1,2,4]tRIAZOL-1-IL]BENZOICO
TWI488624B (zh) 2008-09-22 2015-06-21 Nat University Corp Asahikawa Medical College 鐵螯合劑、其製造方法及鐵離子之定量、捕捉方法
EP2929877A1 (en) * 2010-07-08 2015-10-14 ratiopharm GmbH Oral dosage form of deferasirox
AP3578A (en) 2010-10-01 2016-02-08 Cipla Ltd Pharmaceutical composition comprising deferasirox
JP5900968B2 (ja) 2011-01-14 2016-04-06 株式会社ダステック 高分子鉄キレート剤
CA2885394A1 (en) 2012-11-12 2014-05-15 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
PL3124018T3 (pl) * 2013-03-08 2018-05-30 Novartis Ag Doustne formulacje deferazyroksu
CA2911671A1 (en) 2013-05-10 2014-11-13 Cipla Limited Low dose pharmaceutical composition
EP2946771B1 (en) 2014-05-20 2019-03-20 Sanovel Ilac Sanayi ve Ticaret A.S. Water-dispersible tablet formulation comprising deferasirox
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
US10888519B2 (en) * 2016-07-05 2021-01-12 Jubilant Generics Limited Immediate release pharmaceutical composition of iron chelating agents
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE4412117A1 (de) * 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
EP1058538B9 (en) * 1998-03-06 2013-01-02 Aptalis Pharma S.r.l. Fast disintegrating tablets
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
WO2001086914A2 (en) * 2000-05-08 2001-11-15 Broadcom Corporation System and method for supporting multiple voice channels
WO2002069933A1 (fr) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Comprimés à délitement rapide dans la bouche
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
BRPI0509645A (pt) 2007-09-18
US20080312302A1 (en) 2008-12-18
AR048864A1 (es) 2006-06-07
AU2009201696A1 (en) 2009-05-21
EP1734924A1 (en) 2006-12-27
AU2005230402A1 (en) 2005-10-20
PA8629501A1 (es) 2005-11-25
WO2005097062A1 (en) 2005-10-20
CN1997348A (zh) 2007-07-11
GB0408078D0 (en) 2004-05-12
PE20060717A1 (es) 2006-08-02
RU2006139000A (ru) 2008-05-20
RU2396954C2 (ru) 2010-08-20
CA2559739A1 (en) 2005-10-20
JP2007532509A (ja) 2007-11-15

Similar Documents

Publication Publication Date Title
TW200603841A (en) Dispersible tablets comprising a benzoic acid derivative
MY140999A (en) Dispersible tablets comprising a benzoic acid derivative
TNSN04213A1 (en) High drug load tablet
TNSN08173A1 (en) Dispersible tablets comprising deferasirox
WO2005089729A3 (en) Galenic formulations of organic compounds
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
WO2003063864A3 (fr) Composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
NZ600231A (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
WO2007014124A3 (en) High drug load formulations and dosage forms
WO2005070427A8 (en) Compounds for the sustained reduction of body weight
TN2009000487A1 (en) Triazol compounds for treating biofilm formation
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
WO2005058890A3 (en) Hydronopol derivatives as agonists on human orl1 receptors
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
TN2010000120A1 (en) Galenical formulations of organic compounds
WO2008065144A3 (en) Galenic formulations of organic compounds
TW200716114A (en) Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2007052167A3 (en) Stable composition for a pharmaceutical formulation containing olanzapine
WO2007006738A3 (en) Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
WO2009047904A1 (ja) ウラシル誘導体を有効成分とする炎症性腸疾患治療薬
TW200607498A (en) Agents for prevention or treatment of diseases associated with endothelial hyperproliferation
TH85778B (th) ยาเม็ดที่สามารถแพร่กระจายซึ่งประกอบด้วยอนุพันธ์เบนโซอิกเอซิค (Dispersible tablets comprising a benzoic acid derivative)
CA2516433A1 (en) Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome